Literature DB >> 3474393

Severe cardiopathy in branching enzyme deficiency.

S Servidei, R E Riepe, C Langston, L Y Tani, J T Bricker, N Crisp-Lindgren, H Travers, D Armstrong, S DiMauro.   

Abstract

A 7 1/2-year-old girl had exercise intolerance and exertional dyspnea. Four months later, congestive heart failure developed, with recurrent chylous pleural effusions, and she died at age 8 1/2 years. Endomyocardial biopsy tissue showed abundant PAS-positive, diastase-resistant cytoplasmic deposits. Similar inclusions were seen in muscle, skin, and liver specimens. Postmortem studies showed that the abnormal polysaccharide was especially abundant in heart and muscle, but was also present in all other tissues, including the central nervous system. Glycogen isolated from heart, muscle, and spinal cord showed a shift of the iodine spectrum toward higher than normal wavelengths. Branching enzyme activity was lacking in the muscle biopsy specimen and in all postmortem tissues; glycogenolytic enzymes had normal activities. These studies show that cardiomyopathy can be the first symptom of generalized branching enzyme deficiency and that the degree of accumulation of the abnormal polysaccharide may vary in different tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474393     DOI: 10.1016/s0022-3476(87)80341-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

1.  Glycogen storage disease type IV presenting as hydrops fetalis.

Authors:  A Alegria; E Martins; M Dias; A Cunha; M L Cardoso; I Maire
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

3.  [Polyglycosan body myopathy].

Authors:  M Jeub; K Kappes-Horn; C Kornblum; D Fischer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

Review 4.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

5.  Liver transplantation for type IV glycogen storage disease.

Authors:  R Selby; T E Starzl; E Yunis; B I Brown; R S Kendall; A Tzakis
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

6.  Glycogenosis type IV: liver transplant at 12 years.

Authors:  A Dhawan; K C Tan; B Portmann; A P Mowat
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

Review 7.  Neuromuscular disorders of glycogen metabolism.

Authors:  Elisabetta Gazzerro; Antoni L Andreu; Claudio Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 8.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

9.  Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).

Authors:  J M Schröder; R May; Y S Shin; M Sigmund; S Nase-Hüppmeier
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.

Authors:  A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.